Equities

Beijing Tongrentang Co Ltd

600085:SHH

Beijing Tongrentang Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)42.69
  • Today's Change0.51 / 1.21%
  • Shares traded19.84m
  • 1 Year change-14.72%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Beijing Tongrentang Co Ltd grew revenues 16.19% from 15.37bn to 17.86bn while net income improved 16.92% from 1.43bn to 1.67bn.
Gross margin44.48%
Net profit margin13.33%
Operating margin16.17%
Return on assets7.88%
Return on equity12.63%
Return on investment15.63%
More ▼

Cash flow in CNYView more

In 2023, Beijing Tongrentang Co Ltd did not generate a significant amount of cash. However, the company earned 1.87bn from its operations for a Cash Flow Margin of 10.47%. In addition the company used 76.18m on investing activities and also paid 1.43bn in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share9.46
Tangible book value per share8.87
More ▼

Balance sheet in CNYView more

Beijing Tongrentang Co Ltd has a Debt to Total Capital ratio of 17.65%, a lower figure than the previous year's 18.30%.
Current ratio2.86
Quick ratio1.58
Total debt/total equity0.3387
Total debt/total capital0.1765
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 56.25% and 17.04%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.09%
Div growth rate (5 year)13.97%
Payout ratio (TTM)69.07%
EPS growth(5 years)8.03
EPS (TTM) vs
TTM 1 year ago
-10.22
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.